XML 76 R62.htm IDEA: XBRL DOCUMENT v3.23.3
Business Segment Information - Summary of EBIDTA by Reporting Segment (Detail) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Segment Reporting Information [Line Items]        
Consolidated adjusted EBITDA $ 13,521 $ 14,255 $ 26,644 $ 32,787
Interest expense, net 1,576 277 4,131 1,059
Depreciation and amortization 13,097 7,570 39,094 21,598
Share-based compensation expense 6,274 4,729 32,540 13,521
Foreign exchange impact 1,909 3,253 1,057 7,486
SeaSpine merger-related costs 5,416   34,362  
Strategic investments 913 3,390 1,883 6,184
Acquisition-related fair value adjustments 7,122 419 26,907 (15,795)
Legal judgments/settlements 3,851 125 5,611 466
Medical device regulation 1,840 2,590 7,519 6,883
Business interruption - COVID-19   1,215   1,874
All other (92) 59 170 230
Loss before income taxes (28,385) (9,372) (126,630) (10,719)
Operating Segments [Member] | Global Spine [Member]        
Segment Reporting Information [Line Items]        
Consolidated adjusted EBITDA 22,593 16,601 58,832 45,244
Operating Segments [Member] | Global Orthopedics [Member]        
Segment Reporting Information [Line Items]        
Consolidated adjusted EBITDA 477 2,648 386 2,624
Corporate, Non-Segment [Member]        
Segment Reporting Information [Line Items]        
Consolidated adjusted EBITDA $ (9,549) $ (4,994) $ (32,574) $ (15,081)